Phospho-AKT expression and prognosis of locally advanced prostate cancer: A study based on RTOG 8610

被引：0
|
作者：
Zhai, G
Ho, A
Hammond, E
Fontanesi, J
Rotman, M
Pilepich, M
Shipley, W
Sandler, H
Pollack, A
Zhan-, M
Chakravarti, A
机构：
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA
[2] Amer Coll Radiol, Philadelphia, PA USA
[3] Latter Day St Hosp, Salt Lake City, UT 84143 USA
[4] Michigan Canc Res Inst, Michigan, MI USA
[5] SUNY Hlth Ctr, Brooklyn Inst, New York, NY USA
[6] Univ Calif Los Angeles, Los Angeles, CA 90024 USA
[7] Univ Michigan, Med Ctr, Ann Arbor, MI 48109 USA
[8] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2005年 / 63卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2005.07.546
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2152
引用
收藏
页码：S319 / S319
页数：1
相关论文
共 50 条
  • [31] Expression of Abelson-Interactor Protein 1 (ABI-1) in Breast Cancer and Its Association with Phospho-AKT
    Tran-Thanh, D.
    Wang, C.
    Cawthorn, T.
    Wang, D.
    McCready, D. R.
    Done, S. J.
    [J]. LABORATORY INVESTIGATION, 2009, 89 : 343A - 343A
  • [32] Diabetes and mortality in men with locally advanced prostate cancer: analyses of RTOG 92-02
    Smith, M. R.
    Kyounghwa, B.
    Efstathiou, J. A.
    Hanks, G. E.
    Pilepich, M. V.
    Sandler, H. M.
    Shipley, W. U.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [33] Expression of Abelson-Interactor Protein 1 (ABI-1) in Breast Cancer and Its Association with Phospho-AKT
    Tran-Thanh, D.
    Wang, C.
    Cawthorn, T.
    Wang, D.
    McCready, D. R.
    Done, S. J.
    [J]. MODERN PATHOLOGY, 2009, 22 : 343A - 343A
  • [34] Postneoadjuvant hormone PSA levels and prognosis in locally advanced prostate cancer
    Velasco, J
    Tekyi-Mensah, S
    Bolton, S
    Forman, JD
    [J]. UROLOGY, 1999, 54 (02) : 325 - 328
  • [35] Controversies in the radiotherapeutic management of poor prognosis locally advanced prostate cancer
    Henry, AM
    Price, P
    Logue, JP
    Cowan, RA
    Shanks, JH
    Dearnaley, DP
    Khoo, VS
    [J]. CLINICAL ONCOLOGY, 2004, 16 (02) : 87 - 94
  • [36] ROLE OF LOSS OF PTEN IN PHOSPHO-AKT (P-AKT) POSITIVE PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) TREATED WITH GEFITINIB
    Cappuzzo, Federico
    Magrini, Elisabetta
    Bartolini, Stefania
    Ludovini, Vienna
    Ceresoli, Giovanni
    Lombardo, Laura
    Gregorc, Vanesa
    Ligorio, Claudia
    Damiani, Stefania
    Crino, Lucio
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 7 - 8
  • [37] Loss of p16 expression is of prognostic significance in locally advanced prostate cancer: An analysis from RTOG 86-10
    Chakravarti, A
    Heydon, K
    Wu, CL
    Hammond, E
    Pollack, A
    Roach, M
    Wolkov, H
    Okunieff, P
    Komaki, R
    Fontanesi, J
    Abrams, R
    Pilepich, M
    Shipley, W
    [J]. JOURNAL OF UROLOGY, 2002, 167 (04): : 337 - 337
  • [38] Diabetes and Mortality in Men With Locally Advanced Prostate Cancer: RTOG 92-02 Editorial Comment
    Smith, M. R.
    Bae, K.
    Efstathiou, J. A.
    Hanks, G. E.
    Pilepich, M. V.
    Sandler, H. M.
    Shipley, W. U.
    [J]. JOURNAL OF UROLOGY, 2009, 181 (06): : 2533 - 2533
  • [39] PTEN, Phospho-Akt and IGF-1 Receptor Expression in Triple Negative Breast Cancers: An Immunohistochemical Study with Outcome Correlation
    Tan, P. H. H.
    Thike, A. A.
    Cheok, P. Y.
    [J]. MODERN PATHOLOGY, 2011, 24 : 66A - 66A
  • [40] PTEN, Phospho-Akt and IGF-1 Receptor Expression in Triple Negative Breast Cancers: An Immunohistochemical Study with Outcome Correlation
    Tan, P. H. H.
    Thike, A. A.
    Cheok, P. Y.
    [J]. LABORATORY INVESTIGATION, 2011, 91 : 66A - 66A
12345